Securities code: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) securities abbreviation: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) Announcement No.: 2022014 Shenzhen Bioeasy Biotechnology Co.Ltd(300942)
Announcement on the progress of cooperative investment with professional investment institutions
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Overview of investment matters
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) (hereinafter referred to as “the company”) held the 10th meeting of the 2nd board of directors and the 10th meeting of the 2nd board of supervisors on February 25, 2022, and deliberated and adopted the proposal on cooperative investment with professional investment institutions. In order to make better use of the strength and resource advantages of professional investment institutions, carry out the industrial layout related to the company’s business and improve the company’s comprehensive competitiveness, It is agreed that the company, Shenzhen Ruihai private equity investment fund management Co., Ltd. (hereinafter referred to as “Ruihai investment”) and natural persons Zhou Jinquan and Lu Ye cooperate to establish Shenzhen Zhengrui investment partnership (limited partnership) (hereinafter referred to as “partnership”), with an initial scale of RMB 100 million, The general partner and fund manager invest for Ruihai. As a limited partner, the company subscribed capital contribution of 89 million yuan, accounting for 89%, and the capital contribution method is its own capital in currency. For details, please refer to cninfo.com.cn on February 26, 2022 Announcement on cooperative investment with professional investment institutions (Announcement No.: 2022012).
Recently, the partnership has completed the industrial and commercial registration procedures and obtained the business license issued by Bao’an Supervision Bureau of Shenzhen market supervision administration. The main information is as follows:
2、 Basic information of the partnership
1. Unified social credit Code: 91440300ma5h80xf87
2. Company name: Shenzhen Zhengrui investment partnership (limited partnership)
3. Enterprise type: limited partnership
4. Main business premises: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) building, Liuxian 1st Road, Xingdong community, Xin’an street, Bao’an District, Shenzhen
5. Executive partner: Shenzhen Ruihai private equity investment fund management Co., Ltd. (appointed representative: Guo Zhe)
6. Registered capital: RMB 100 million
7. Date of establishment: February 2023
8. Term of partnership: March 2, 2022 to March 1, 2029
9. Business scope: engaging in investment activities with its own funds. (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)
3、 Description of other matters
1. Ruihai investment, the executive partner of the partnership, still needs to complete the registration procedures of private fund manager of China Securities Investment Fund Industry Association.
2. The partnership still needs to complete the filing of private investment funds with the China Securities Investment Fund Industry Association.
The company will fulfill the obligation of information disclosure in time according to relevant regulations. Please pay attention to investment risks. 4、 Documents for future reference
Shenzhen Ruizheng partnership investment Co., Ltd
It is hereby announced.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) board of directors March 5, 2022
